The first is to investigate potential correlations between established AD biomarkers (CSF tau, p-tau181, and Aβ42) and FC in the DMN using resting state fMRI (adjusting for age, gender, and the APOE4 genotype) in AD and controls. Here, MAPT is linked to Alzheimer disease.